课题基金 / 基金详情

The predictive ability of endogenous secretory receptor for advanced glycation end products for fragility Fractures and cardiovascular diseases.

The predictive ability of endogenous secretory receptor for advanced glycation end products for fragility Fractures and cardiovascular diseases.
内源性分泌受体对脆性骨折和心血管疾病的晚期糖基化终产物的预测能力。
批准号:
24659332
负责人:
TAMAKI Junko
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

TAMAKI Junko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We conducted the 5-year follow-up survey of FORMEN Study which enrolled 2012 men at the baseline, as part of a prospective cohort study of Fujiwara-kyo study. There was no significant difference in esRAGE values at the baseline survey in men who suffered coronary artery diseases when compared to men who did not. The higher values of esRAGE were significantly correlated with the lower values of intima-media thickness of carotid artery (IMT) measured at the 5-year follow-up survey, while there was no significant correlation between esRAGE- to pentosidine ratio and IMT values. Higher values of esRAGE-to-pentosidine ratio were associated with a decreased risk of fragility fractures independently of age and BMD among Japanese elderly men.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
男性骨粗鬆症コホート研究5年次追跡による脆弱性骨折のリスク要因の検討-FORMEN Study
通过男性骨质疏松症队列研究的 5 年随访检查脆性骨折的危险因素 - FORMEN 研究
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [T Ogawa, K Zaitsu, T Kokaji, T Suga, M Iwai, H Hattori, H Tsuchihashi, O Suzuki, A Ishii, H Seno, 玉置淳子]
通讯作者: 玉置淳子
Serum Pentosidine and its Decoy Receptor, endogenous secretory receptor for Advanced Glycation End Products, Predict Fragility Fractures in Elderly Men : the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study
血清戊糖素及其诱饵受体(高级糖基化终产物的内源性分泌受体)可预测老年男性的脆性骨折:Fujiwara-kyo 男性骨质疏松症风险 (FORMEN) 研究
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [T Ogawa, K Zaitsu, T Kokaji, T Suga, M Iwai, H Hattori, H Tsuchihashi, O Suzuki, A Ishii, H Seno, 玉置淳子, Tamaki J.]
通讯作者: Tamaki J.
INCIDENT CLINICAL FRACTURE INCREASES THE RISK OF MORTALITY IN COMMUNITY-DWELLING ELDERLY MEN: FUJIWARA-KYO OSTEOPOROSIS RISK IN MEN (FORMEN) STUDY
意外发生的临床骨折会增加社区老年男性的死亡风险:藤原京男性 (Formen) 研究中的骨质疏松症风险
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Iki M, Fujita Y, Tamaki J, Kouda K, Yura A, Kadowaki E, Sato Y, Moon J.S, Harano A, Hazaki K, Okamoto N, Kurumatani N.]
通讯作者: Kurumatani N.
高齢男性の新規骨折は生命予後を悪化させる : 藤原京スタディ男性骨粗鬆症研究
老年男性新发骨折使生活预后恶化:Fujiwara Kyo 对男性骨质疏松症的研究
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [伊木雅之]
通讯作者: 伊木雅之
Are high serum sclerostin levels, bone formation inhibitory factor, associated with a decreased risk of vascular calcification? A long term cohort study for Multi-organ association
  • 批准号:
    16K15384
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2016
  • 负责人:
    TAMAKI Junko
  • 依托单位:
The effect of osteoporotic fractures for progress of arteriosclerosis based on bone vascular correlation: 20-years follow-up of a large cohort study with randomized sampled women
  • 批准号:
    15H04789
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.4万
  • 财政年份:
    2015
  • 负责人:
    TAMAKI Junko
  • 依托单位:
The model for fragility fracture predictions: a 15-year follow-up study of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
The fracture risk assessment tool using bone mineral density, risk factors and biochemical marker of bone turnover
  • 批准号:
    20590661
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2008
  • 负责人:
    TAMAKI Junko
  • 依托单位:
国内基金
海外基金
基于BMP2/Smad1/Runx2通路调控干细胞成骨分化及桃红四物汤促进骨折愈合的研究
  • 批准号:
    2026JJ80308
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    贺渊哲
  • 依托单位:
基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
  • 批准号:
    2026JJ80362
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周新
  • 依托单位:
社交隔离通过TIM3/cGAS/STING信号通路增加骨折风险的机制研究
  • 批准号:
    2026JJ60651
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周剑
  • 依托单位:
基于天然高分子改性的可注射智能水凝胶在加速眼眶骨折修复中的研究